Showing results (101-110 of 279) with videos related to

Sort By:
Pageof 28
Kidney International|September 16, 2011
Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritisSean J Barbour, Allen Greenwald, Ognjenka Djurdjev, et al.
Kidney International|March 27, 2026
Complement inhibitors and B-cell modifying agents for IgA nephropathy- a KDIGO commentaryBrad H Rovin, Jonathan Barratt, H Terence Cook, et al.
International Journal of Surgical Pathology|March 1, 2005
Primary alveolar soft part sarcoma (ASPS) of the breast: report of a deceptive case with xanthomatous features confirmed by TFE3 immunohistochemistry and electron microscopyJulie Wu, David A Brinker, Mark Haas, et al.
Pediatric Nephrology (Berlin, Germany)|July 2, 2003
Bartter syndrome complicated by immune complex nephropathy. Case report and literature reviewYahya Sardani, Kenan Qin, Mark Haas, et al.
The Journal of Pediatrics|May 13, 2018
Social Determinants of Health Are Associated with Markers of Renal Injury in Adolescents with Type 1 DiabetesLaura A M Cummings, Antoine Clarke, Etienne Sochett, et al.
Rheumatology (Oxford, England)|December 16, 2010
Glomerular filtration rate predicts arterial events in women with systemic lupus erythematosusWendy Zhang, Elaheh Aghdassi, Heather N Reich, et al.
Journal of the American Society of Nephrology : JASN|January 30, 2021
Quantifying Duration of Proteinuria Remission and Association with Clinical Outcome in IgA NephropathyMark Canney, Sean J Barbour, Yuyan Zheng, et al.
Kidney International Reports|January 10, 2022
Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 IntegrinMichelle A Hladunewich, Dan Cattran, Sanjeev M Sethi, et al.
American Journal of Physiology. Renal Physiology|January 24, 2018
Hyperfiltration, urinary albumin excretion, and ambulatory blood pressure in adolescents with Type 1 diabetes mellitusJulie A Lovshin, Marko Škrtić, Petter Bjornstad, et al.
Lancet (London, England)|August 17, 2023
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trialRichard Lafayette, Jens Kristensen, Andrew Stone, et al.
Pageof 28